Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins

Stem Cells Translational Medicine

Volumn 3, Issue 12, 2014, Pages 1526-1534

  Hu, Qirui ^a   Chen, Renwei ^a,b   Teesalu, Tambet ^a,b   Ruoslahti, Erkki ^a,b   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Cell penetrating peptide; Lineage reprogramming; Neuron; Protein transduction; Retinal pigmented epithelium

Indexed keywords

BETA TUBULIN; LENTIVIRUS VECTOR; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; NEUROFILAMENT M PROTEIN; NEUROPILIN 1; NEUROPILIN 2; NUCLEAR FACTOR Y; OCTAMER TRANSCRIPTION FACTOR 4; RECOMBINANT PROTEIN; SONIC HEDGEHOG PROTEIN; SYNAPSIN; SYNAPTOBREVIN 2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; VESICULAR GLUTAMATE TRANSPORTER 1; DIFFERENTIATION ANTIGEN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; BINDING ASSAY; DEPOLARIZATION; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NUCLEAR EXPORT SIGNAL; NUCLEAR REPROGRAMMING; PIGMENT CELL; PROTEIN EXPRESSION; RETINAL PIGMENTED EPITHELIAL CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; BIOSYNTHESIS; CYTOLOGY; GENETICS; METABOLISM; NEURITE; PIGMENT EPITHELIUM;

ANTIGENS, DIFFERENTIATION; CELLULAR REPROGRAMMING; HUMANS; NEURITES; RETINAL PIGMENT EPITHELIUM; SOXB1 TRANSCRIPTION FACTORS;

EID: 84913543928     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0038     Document Type: Article

References (47)

1. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNAconverts fibro-blasts to myoblasts. Cell 1987;51:987–1000.
2. Nutt SL, Heavey B, Rolink AG et al. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999; 401:556–562.
3. Berninger B, Costa MR, Koch U et al. Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J Neu-rosci 2007;27:8654–8664.
4. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861–872.
5. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035–1041.
6. Xie H, Ye M, Feng R et al. Stepwise reprog-rammingofBcells into macrophages. Cell 2004; 117:663–676.
7. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripo-tent stem cells. Nature 2007;448:313–317.
8. Ben-David U, Benvenisty N, Mayshar Y. Genetic instability in human induced pluripo-tent stem cells: Classificationof causes and possible safeguards. Cell Cycle 2010;9:4603–4604.
9. Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in he-matopoietic cells. Mol Ther 2006;13:1031–1049.
10. Stadtfeld M, Nagaya M, Utikal J et al. Induced pluripotent stem cells generated without viral integration. Science 2008;322: 945–949.
11. Yu J, Chau KF, Vodyanik MA et al. Efficient feeder-free episomal reprogramming with small molecules. PLoS One 2011;6:e17557.
12. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797–801.
13. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008;322: 949–953.
14. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4: 381–384.
15. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472–476.
16. Teesalu T, Sugahara KN, Kotamraju VR et al. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA 2009;106:16157–16162.
17. Alberici L, Roth L, Sugahara KN et al. De novo design of a tumor-penetrating peptide. Cancer Res 2013;73:804–812.
18. Sugahara KN, Teesalu T, Karmali PP et al. Coadministration of a tumor-penetrating pep-tide enhances the efficacy of cancer drugs. Science 2010;328:1031–1035.
19. Sugahara KN, Teesalu T, Karmali PP et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 2009; 16:510–520.
20. Roth L, Agemy L, Kotamraju VR et al. Transtumoral targeting enabled by a novel neuropilin-bindingpeptide. Oncogene 2012;31: 3754–3763.
21. Zhao S, Thornquist SC, Barnstable CJ. In vitro transdifferentiation of embryonic rat retinal pigment epithelium to neural retina. Brain Res 1995;677:300–310.
22. Yan RT, Li X, Wang SZ. Photoreceptor-like cells in transgenic mouse eye. Invest Ophthal-mol Vis Sci 2013;54:4766–4775.
23. Ma W, Yan RT, Li X et al. Reprogramming retinal pigment epithelium to differentiate toward retinal neurons with Sox2. Stem Cells 2009;27:1376–1387.
24. Avilion AA, Nicolis SK, Pevny LH et al. Mul-tipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003;17:126–140.
25. Wood HB, Episkopou V. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech Dev 1999;86:197–201.
26. Yabuta Y, Kurimoto K, Ohinata Y et al. Gene expression dynamics during germline specification in mice identified by quantitative single-cell gene expression profiling. Biol Reprod 2006;75:705–716.
27. Thomson M, Liu SJ, Zou LN et al. Pluripo-tency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011; 145:875–889.
28. Wang Z, Oron E, Nelson B et al. Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 2012;10:440–454.
29. Pevny LH, Nicolis SK. Sox2 roles in neural stem cells. Int J Biochem Cell Biol 2010;42: 421–424.
30. Wegner M, Stolt CC. From stem cells to neurons and glia: A Soxist’s view of neural development. Trends Neurosci 2005;28:583–588.
31. Graham V, Khudyakov J, Ellis P et al. SOX2 functions to maintain neural progenitor identity. Neuron 2003;39:749–765.
32. Taranova OV, Magness ST, Fagan BM et al. SOX2isadose-dependent regulatorofret-inal neural progenitor competence. Genes Dev 2006;20:1187–1202.
33. Cavallaro M, Mariani J, Lancini C et al. Impaired generation of mature neurons by neural stemcells fromhypomorphicSox2 mutants. De-velopment 2008;135:541–557.
34. Ferri AL, Cavallaro M, Braida D et al. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 2004;131:3805–3819.
35. Ring KL, Tong LM, Balestra ME et al. Direct reprogrammingofmouseand human fibro-blasts into multipotent neural stem cells with a single factor. Cell Stem Cell 2012;11:100–109.
36. Maucksch C, Jones KS, Connor B. Concise review: The involvement of SOX2 in direct reprog-ramming of induced neural stem/precursor cells. Stem Cells Translational Medicine 2013;2:579–583.
37. Hu Q, Friedrich AM, Johnson LV et al. Memory in induced pluripotent stem cells: Reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010;28:1981–1991.
38. Wang SZ, Ma W, Yan RT et al. Generating retinal neurons by reprogramming retinal pigment epithelial cells. Expert Opin Biol Ther 2010;10:1227–1239.
39. Rowland TJ, Blaschke AJ, Buchholz DE et al. Differentiationofhuman pluripotent stem cells to retinal pigmented epithelium indefined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med 2013;7:642–653.
40. Amaral E, Guatimosim S, Guatimosim C. Using the fluorescent styryl dye FM1-43 to visualize synaptic vesicles exocytosis and endocyto-sis in motor nerve terminals. Methods Mol Biol 2011;689:137–148.
41. Bolte S, Talbot C, Boutte Y et al. FM-dyes as experimental probes for dissecting vesicle trafficking in living plant cells. J Microsc 2004; 214:159–173.
42. MacEwan SR, Chilkoti A. Harnessing the power of cell-penetrating peptides: Activatable carriersfor targetingsystemicdeliveryofcancer therapeutics and imaging agents. Wiley Inter-discip Rev Nanomed Nanobiotechnol 2013;5: 31–48.
43. Katayama S, Nakase I, Yano Y et al. Effects of pyrenebutyrate on the translocation of arginine-rich cell-penetrating peptides through artificial membranes: Recruitingpeptidestothe membranes, dissipating liquid-ordered phases, and inducing curvature. Biochim Biophys Acta 2013;1828:2134–2142.
44. Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol 2000;10:290–295.
45. Cho HJ, Lee CS, Kwon YW et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 2010;116:386–395.
46. Croze RH, Buchholz DE, Radeke MJ et al. ROCK inhibition extends passage of pluripotent stem cell-derived retinal pigmented epithelium. Stem Cells Translational Medicine 2014; 3:1066–1078.
47. Salero E, Blenkinsop TA, Corneo B et al. Adult human RPE can be activated into a mul- tipotent stem cell that produces mesenchy- mal derivatives. Cell Stem Cell 2012;10: 88–95.